Differential Role of μ- and κ-Opiate Receptors in Anterior Pituitary Hormone Secretion

  • D. G. Pfeiffer
  • A. Pfeiffer
Conference paper

Abstract

Morphine and other opioids are known to affect the release of most anterior pituitary hormones. These actions are thought to be mediated by an interaction with hypothalamic factors which are secreted into the hypothalamo-pituitary circulation (for review see Illes 1989; Pfeiffer and Herz 1984; Millan and Herz 1985). The presence of at least three distinct types of opiate receptors named μ (my), δ (delta) and κ (kappa) is generally accepted and ligands which selectively activate or block these receptors are now available. The existence of several distinct subtypes of opiate receptors not only adds another level of complexity to the analysis of opioid systems; it also raises the question whether there may exist particular physiological functions of, for example, μ- or κ-opiate receptors. In this case, it may become possible to selectively manipulate certain aspects of the endocrine function of opioids.

Keywords

Luteinizing Hormone Corticotropin Release Hormone Endogenous Opioid Opiate Receptor Luteinizing Hormone Release Hormone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Attali B, Gouardieres C, Mazarguil H, Audigier Y, Cros J (1982) Evidence for multiple “kappa” binding sites by use of opioid peptides in the guinea pig lumbo-sacral spinal cord. Neuropeptides 3: 53–64PubMedCrossRefGoogle Scholar
  2. Blankstein J, Reyes FI, Winter JSD, Fairman C (1981) Endorphins and the regulation of the human menstrual cycle. Clin Endocrinol 14: 287–294CrossRefGoogle Scholar
  3. Bruni F, van Vugt D, Marshall S, Meites J (1977) Effects of naloxone, morphine and methionine enkephalin on serum prolactin, luteinizing hormone, follicle stimulating hormone, thyroid stimulating hormone and GH. Life Sci 21:461–466PubMedCrossRefGoogle Scholar
  4. Ching M (1983) Morphine suppresses the proestrous surge of GnRH in pituitary portal plasma of rats. Endocrinology 112: 2209–2211PubMedCrossRefGoogle Scholar
  5. Cicero TJ, Schainker BA, Meyer ER (1979) Endogenous opioids participate in the regulation of the hypothalamic-pituitary- luteinizing hormone axis and testosterone’s negative feedback control of luteinizing hormone. Endocrinology 104: 1286–1291PubMedCrossRefGoogle Scholar
  6. Eisenberg RM (1980) Effects of naloxone on plasma corticosterone in opiate naive rats. Life Sci 26: 935–943PubMedCrossRefGoogle Scholar
  7. George R, Way EL (1959) The role of the hypothalamus in pituitary adrenal activation and antidiuresis by morphine. J Pharmacol Exp Ther 125: 111–115PubMedGoogle Scholar
  8. Gillies GE, Linton EA, Lowry PJ (1982) Corticotrophin releasing activity of the new CRF is potentiated several times by vasopressin. Nature 299: 355–357PubMedCrossRefGoogle Scholar
  9. Goodman RR, Snyder SH, Kuhar MJ, Young WS III (1980) Differentiation of μ-and κ-opiate receptors by light microscopic autoradiography. Proc Natl Acad Sci USA 77: 6239–6242PubMedCrossRefGoogle Scholar
  10. Illes P (1989) Modulation of transmitter and hormone release by multiple opioid receptors. Rev Physiol Biochem Pharmacol 112: 139–233PubMedCrossRefGoogle Scholar
  11. Krulich L, Koenig JI, Conway S, McCann SM, Mayfield MA (1986) Opioid κ-receptors and the secretion of PRL and GH in the rat. Neuroendocrinology 99: 411–418.Google Scholar
  12. Leadem CA, Kalra SP (1985) Effects of endogenous opioid peptides and opiates on luteinizing hormone and prolactin secretion in ovariectomized rats. Neuroendocrinology 41: 342–352PubMedCrossRefGoogle Scholar
  13. Leadem CA, Yagenova SV (1987) Effects of specific activation of μ-, δ and κ-opioid receptors on the secretion of luteinizing hormone and prolactin in ovariectomized rats. Neuroendocrinology 45: 109–117PubMedCrossRefGoogle Scholar
  14. Linton EA, Tilders FJH, Hodgkinson S, Berkenbosch F, Vermes I, Lowry PJ (1985) Stress induced secretion of corticotrophin is inhibited by antisera to ovine CRF and vasopressin. Endocrinology 116: 966–970PubMedCrossRefGoogle Scholar
  15. McDonald RK, Evans FT, Weise VK, Patrick RW (1959) Effect of morphine and nalorphine on plasma hydrocortisone levels in man. J Pharmacol Exp Ther 125: 241–247PubMedGoogle Scholar
  16. Millian MJ, Herz A (1985) The endocrinology of the opioids. Int Rev Neurobiol 26: 1–83CrossRefGoogle Scholar
  17. Nikolarakis K, Pfeiffer DG, Almeida OFX, Herz A (1986) Opioid modulation of LHRH-release in vitro depends on levels of testosterone in vivo. Neuroendocrinology 44: 314–319PubMedCrossRefGoogle Scholar
  18. Nikolarakis K, Pfeiffer A, Stalla GK, Herz A (1987) The role of CRF in the release of ACTH by opioid agonists and antagonists in rats. Brain Res 421: 373–376PubMedCrossRefGoogle Scholar
  19. Nikolarakis K, Pfeiffer A, Stalla GK, Herz A (1989) The role of the sympathetic nervous system and CRH in morphine-stimulated release of ACTH in rats. Brain Res (in press)Google Scholar
  20. Pechnik R, George R, Poland RE (1985) Identification of multiple opiate receptors through neuroendocrine responses. I. Effects of agonists. J Pharmacol Exp Ther 232: 163–169Google Scholar
  21. Pfeiffer A, Pasi A, Mehrain P, Herz A (1981) A subclassification of κ-opiate receptors in human brain by use of dynorphin 1–17. Neuropeptides 2: 87–96CrossRefGoogle Scholar
  22. Pfeiffer A, Pasi A, Mehraein P, Herz A (1982) Opiate receptor binding sites in human brain. Brain Res 248: 87–96PubMedCrossRefGoogle Scholar
  23. Pfeiffer A, Feuerstein G, Zerbe RL, Faden AI, Kopin IJ (1983) μ-Receptors mediate opioid cardiovascular effects at anterior hypothalamic sites through sympatho-adrenomedullary and parasympathetic pathways. Endocrinology 113: 929–938PubMedCrossRefGoogle Scholar
  24. Pfeiffer A, Herz A (1984) Endocrine actions of opioids. Horm Metab Res 16: 386–397PubMedCrossRefGoogle Scholar
  25. Pfeiffer A, Herz A, Loriaux DL, Pfeiffer DG (1985) Central κ- and μ- opiate receptors mediate ACTH-release in rats. Endocrinology 116: 2688–2690PubMedCrossRefGoogle Scholar
  26. Pfeiffer A, Braun S, Mann K, Meyer HD, Brantl V (1986a) Anterior pituitary hormone responses to a κ-opioid agonist in man. J Clin Endocrinol Metab 62: 181–185PubMedCrossRefGoogle Scholar
  27. Pfeiffer A, Knepel W, Braun S, Meyer HD, Lohmann H, Brantl V (1986b) Effects of a κ-opioid agonist on adrenocorticotropic and diuretic functions in man. Horm Metab Res 18: 842–848PubMedCrossRefGoogle Scholar
  28. Pfeiffer DG, Nikolarakis K, Pfeiffer A (1984) Chronic blockade of opiate receptors: influence on reproduction and body weight in female rats. Neuropeptides 5: 279–282PubMedCrossRefGoogle Scholar
  29. Pfeiffer DG, Pfeiffer A, Almeida OFX, Herz A (1987) Opiate suppression of LH secretion involves opiate receptors different from those mediating opiate effects on prolactin secretion. J Endocrinol 114: 469–476PubMedCrossRefGoogle Scholar
  30. Quigley ME, Yen SSC (1980) The role of endogenous opioids in LH secretion during the menstrual cycle. J Clin Endocrinol Metab 51: 179–181PubMedCrossRefGoogle Scholar
  31. Stalla GK, Hartwimmer J, Kaliebe T, Müller OA (1985) Radioimmunoassay of human CRF. Acta Endocrinol [Suppl] (Copenh) 267: 108–118Google Scholar
  32. Tsagarakis S, Rees LH, Besser G M, Grossman A (1989) Opiate receptor subtype regulation of CRF-41 release from rat hypothalamus in vitro. Neuroendocrinology (in press)Google Scholar
  33. Volavka J, Baumann J, Pevnick J, Reker D, James B, Cho D (1980) Short term hormonal effects of naloxone in man. Psychoneuroendocrinology 5: 225–234PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • D. G. Pfeiffer
  • A. Pfeiffer

There are no affiliations available

Personalised recommendations